GJIC
MRNA icon

Gamble Jones Investment Counsel’s Moderna MRNA Stock Holding History

Gamble Jones Investment Counsel’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-600
Closed -$231K – 217
2021
Q3 		$231K Buy
+600
New +$221K 0.02% 201

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Gamble Jones Investment Counsel's MRNA Position: Q4 2021 in Review

Gamble Jones Investment Counsel sold out of Moderna (MRNA) in Q4 2021, closing a stake of 600 shares — an estimated $231K sold.

Gamble Jones Investment Counsel first reported a position in MRNA in Q3 2021 and held it in 1 quarter. The position peaked at $231K in Q3 2021. 1,110 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Gamble Jones Investment Counsel reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • Gamble Jones Investment Counsel sold 600 Moderna shares in Q4 2021, an estimated $231K.
  • Gamble Jones Investment Counsel first reported a position in Moderna in Q3 2021 and held it in 1 quarter.
  • Gamble Jones Investment Counsel's Moderna position peaked at $231K in Q3 2021.
  • 1,110 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Gamble Jones Investment Counsel's 13F filing for Q4 2021, filed 9 Feb 2022.